His research at CU Anschutz combines brain imaging, behavioral insights and machine learning to identify patterns that could predict mood disorders early, opening the door to faster and more effective interventions.
His research at CU Anschutz combines brain imaging, behavioral insights and machine learning to identify patterns that could predict mood disorders early, opening the door to faster and more effective interventions.
✅ 27% lower risk of death after discharge
✅ Fewer hospital and ER readmissions within 28 days
Explore the study ➡️ https://cudbmi.info/covid-rdv-2025-1
✅ 27% lower risk of death after discharge
✅ Fewer hospital and ER readmissions within 28 days
Explore the study ➡️ https://cudbmi.info/covid-rdv-2025-1
Check out their sessions and join the conversation ➡️ https://cudbmi.info/amia-2025-1
Check out their sessions and join the conversation ➡️ https://cudbmi.info/amia-2025-1
Learn how DBMI is cultivating reusable, renewable software for science ➡️ cudbmi.info/softwaregarden-1
Learn how DBMI is cultivating reusable, renewable software for science ➡️ cudbmi.info/softwaregarden-1
🧬 Asthma genetics in African-ancestry populations
🧠 ML insights into NF1 cell changes
💊 ICU pharmacists recognized in new national guidelines
🧬 Asthma genetics in African-ancestry populations
🧠 ML insights into NF1 cell changes
💊 ICU pharmacists recognized in new national guidelines
At CU Anschutz, Fan Zhang, PhD, is using single-cell tech and AI to uncover immune cell interactions that could lead to better therapies for rheumatoid arthritis and other autoimmune conditions ➡️ https://bit.ly/4nMHidW
At CU Anschutz, Fan Zhang, PhD, is using single-cell tech and AI to uncover immune cell interactions that could lead to better therapies for rheumatoid arthritis and other autoimmune conditions ➡️ https://bit.ly/4nMHidW
Matthew DeCamp, MD, says we need to ask:
✅ Do patients know it’s AI?
✅Do they understand its limits?
✅Do they have a choice?
Ethics must guide AI in healthcare ➡️ https://bit.ly/4pBvOeK
Matthew DeCamp, MD, says we need to ask:
✅ Do patients know it’s AI?
✅Do they understand its limits?
✅Do they have a choice?
Ethics must guide AI in healthcare ➡️ https://bit.ly/4pBvOeK
CU Anschutz’s Carie Behounek sat down with David Kao, MD, DBMI secondary faculty member, to unpack the promise, pitfalls, and price of AI in breast cancer screening.
Read the Q&A ➡️ https://bit.ly/4nfsPGU
CU Anschutz’s Carie Behounek sat down with David Kao, MD, DBMI secondary faculty member, to unpack the promise, pitfalls, and price of AI in breast cancer screening.
Read the Q&A ➡️ https://bit.ly/4nfsPGU
We were thrilled to host @alice.soragnilab.com from UCLA at @cuanschutz.bsky.social. She’s teaming up with @casey.greenelab.com to drive innovation and improve patient outcomes. This collaboration is a powerful example of how partnerships accelerate scientific discovery.
We were thrilled to host @alice.soragnilab.com from UCLA at @cuanschutz.bsky.social. She’s teaming up with @casey.greenelab.com to drive innovation and improve patient outcomes. This collaboration is a powerful example of how partnerships accelerate scientific discovery.